Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Appointed director
Quarterly results
CC transcript
Appointed CFO
|
|
STREAMLINE HEALTH SOLUTIONS INC. (STRM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/27/2023 |
SC 13G
| GCI Partners Opportunity Fund, LP reports a 6.6% stake in Streamline Health Solutions Inc. |
| 07/11/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 06/28/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 06/28/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 06/12/2023 |
8-K
| Quarterly results|
Docs:
|
"STREAMLINE HEALTH SOLUTIONS, INC. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Three Months Ended April 30, 2023 2022 Revenues: Software as a service $ 3,175,000 $ 2,831,000 Maintenance and support 1,157,000 1,110,000 Professional fees and licenses 1,000,000 1,994,000 Total revenues 5,332,000 5,935,000 Operating expenses: Cost of software as a service 1,589,000 1,497,000 Cost of maintenance and support 89,000 46,000 Cost of professional fees and licenses 1,108,000 1,666,000 Selling, general and administrative expense 3,806,000 4,501,000 Research and development 1,701,000 1,312,000 Acquisition-related costs 35,000 90,000 Total operating expenses 8,328,000 9,112,000 Operating loss Other income: Interest expense Acquisition earnout valuation adjustments 364,000 500,000 Other 32..." |
|
| 05/25/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/10/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/27/2023 |
10-K
| Annual Report for the period ended January 31, 2023 |
| 04/26/2023 |
8-K
| Quarterly results |
| 02/03/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/29/2022 |
8-K
| Quarterly results |
| 12/15/2022 |
10-Q
| Quarterly Report for the period ended October 31, 2022 |
| 12/14/2022 |
8-K
| Quarterly results |
| 12/05/2022 |
8-K
| Quarterly results |
| 11/30/2022 |
SC 13D/A
| Tamarack Advisers, LP reports a 10.7% stake in Streamline Health Solutions Inc. |
| 11/10/2022 |
8-K
| Quarterly results |
| 11/01/2022 |
SC 13D/A
| PESSIN NORMAN H reports a 2.3% stake in Streamline Health Solutions, Inc. |
| 10/27/2022 |
8-K
| Quarterly results |
| 10/25/2022 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 09/14/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/08/2022 |
10-Q
| Quarterly Report for the period ended July 31, 2022 |
| 09/07/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 08/31/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 07/11/2022 |
SC 13G
| Marathon Micro Fund, LP reports a 5.1% stake in Streamline Health Solutions, Inc. |
| 07/06/2022 |
8-K
| Quarterly results |
| 07/05/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 06/22/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 06/22/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 06/09/2022 |
10-Q
| Quarterly Report for the period ended April 30, 2022 |
| 06/08/2022 |
8-K
| Quarterly results |
| 06/08/2022 |
8-K
| Quarterly results |
| 06/03/2022 |
8-K
| Quarterly results |
| 05/09/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/28/2022 |
10-K
| Annual Report for the period ended January 31, 2022 |
|
|
|